Dr. Anke Caßing is a trained scientist with a doctorate who moved from years of strategic marketing and business development experience in medical technology, biotechnology, and pharmaceuticals into venture capital at HTGF, bringing a commercially and clinically grounded investment perspective rather than a purely financial one. She serves as HTGF's go-to commentator on the aging economy opportunity in Germany, discussing how technology and startups can address the needs of older adults—an angle that makes her stand out from more generalist health investors.